76 related articles for article (PubMed ID: 26188382)
1. Rare Occurrence of Incidental Finding of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features in Hürthle Cell Adenoma.
Pigac B; Masic S; Hutinec Z; Masic V
Med Arch; 2018 Nov; 72(5):367-370. PubMed ID: 30524171
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the Enigma: A Five-Year Comprehensive Analysis of Hurthle Cell Tumors in South India's Tertiary Care Center.
Sulaiman S; Chirukandath R; Krishnan SK; Rajesh N; Antony M; Mohan K; S S
Cureus; 2024 Mar; 16(3):e57166. PubMed ID: 38681349
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Paraclinical Considerations Regarding ki67's Role in the Management of Differentiated Thyroid Carcinoma-A Literature Review.
Peștean C; Pavel A; Piciu D
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792952
[No Abstract] [Full Text] [Related]
4. Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.
Nadeem S; Hanna MG; Viswanathan K; Marino J; Ahadi M; Alzumaili B; Bani MA; Chiarucci F; Chou A; De Leo A; Fuchs TL; Lubin DJ; Luxford C; Magliocca K; Martinez G; Shi Q; Sidhu S; Al Ghuzlan A; Gill AJ; Tallini G; Ghossein R; Xu B
Histopathology; 2023 Dec; 83(6):981-988. PubMed ID: 37706239
[TBL] [Abstract][Full Text] [Related]
5. Hürthle cell-predominant thyroid fine needle aspiration cytology: A four risk-factor model highly accurate in excluding malignancy and predicting neoplasm.
Yuan L; Nasr C; Bena JF; Elsheikh TM
Diagn Cytopathol; 2022 Sep; 50(9):424-435. PubMed ID: 35674254
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenic role of NDUFA13 inactivation in spontaneous hepatitis in mice and the mechanism].
Xu X; Li R; Zeng X; Wang X; Xue B; Huang D; Huang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):55-63. PubMed ID: 33509753
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features.
Kure S; Ohashi R
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374707
[TBL] [Abstract][Full Text] [Related]
8. The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function-A Comprehensive Review.
Kumari S; Adewale R; Klubo-Gwiezdzinska J
Cells; 2020 Jun; 9(7):. PubMed ID: 32605113
[TBL] [Abstract][Full Text] [Related]
9. Hürthle Cell Carcinoma in a Lingual Thyroid.
Thakur JS; Verma N; Singh R
Med Princ Pract; 2018; 27(5):489-492. PubMed ID: 29898455
[TBL] [Abstract][Full Text] [Related]
10. Issues in Managing Hurthle Cell Carcinoma of Thyroid: A Case Report.
Tai P; Korzeniowski M; Sadikov E; Joseph K; Kirby A; Tonita J; Mahmud A
Cureus; 2017 Apr; 9(4):e1167. PubMed ID: 28507839
[TBL] [Abstract][Full Text] [Related]
11. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract][Full Text] [Related]
12. [Predictive factors for malignancy in Hürthle-cell thyroid neoplasia. Effect of surgical treatment].
Pisanu A; Aste L; Piu S; Cois A; Uccheddu A
Tumori; 2003; 89(4 Suppl):223-5. PubMed ID: 12903600
[TBL] [Abstract][Full Text] [Related]
13. [Hürthle-cell thyroid neoplasms: a clinical enigma].
Cannizzaro M; Fiorenza G; Garofalo L; De Maria A; Cavallaro N; Pulvirenti A; Veroux PF
Ann Ital Chir; 1999; 70(4):503-8; discussion 508-9. PubMed ID: 10573612
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas.
Pisani T; Pantellini F; Centanni M; Vecchione A; Giovagnoli MR
Anticancer Res; 2003; 23(4):3323-6. PubMed ID: 12926070
[TBL] [Abstract][Full Text] [Related]
16. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
